Douglas W. Losordo - Jan 18, 2024 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Medical Officer
Signature
/s/ Matthew K. Szot, Attorney-in-fact
Stock symbol
CVKD
Transactions as of
Jan 18, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 07:38 PM
Previous filing
Dec 26, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock Options Award $0 +150K $0.00 150K Jan 18, 2024 Common Stock 150K $0.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.